205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-26.45%
Revenue decline while MRVL shows 11.40% growth. Joel Greenblatt would examine competitive position erosion.
-20.07%
Cost reduction while MRVL shows 10.71% growth. Joel Greenblatt would examine competitive advantage.
-33.23%
Gross profit decline while MRVL shows 12.16% growth. Joel Greenblatt would examine competitive position.
-9.22%
Margin decline while MRVL shows 0.68% expansion. Joel Greenblatt would examine competitive position.
-14.99%
R&D reduction while MRVL shows 5.65% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.72%
Operating expenses growth 1.1-1.25x MRVL's 13.74%. Bill Ackman would demand justification.
-7.57%
Total costs reduction while MRVL shows 12.17% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.69%
D&A growth 1.1-1.25x MRVL's 11.18%. Bill Ackman would demand investment justification.
-61.53%
EBITDA decline while MRVL shows 0.86% growth. Joel Greenblatt would examine position.
-47.69%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-93.30%
Both companies show declining income. Martin Whitman would check industry conditions.
-90.89%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-240.00%
Other expenses reduction while MRVL shows 411.90% growth. Joel Greenblatt would examine advantage.
-95.24%
Pre-tax income decline while MRVL shows 83.47% growth. Joel Greenblatt would examine position.
-93.53%
Pre-tax margin decline while MRVL shows 85.16% growth. Joel Greenblatt would examine position.
-136.79%
Tax expense reduction while MRVL shows 44.52% growth. Joel Greenblatt would examine advantage.
-80.99%
Net income decline while MRVL shows 120.09% growth. Joel Greenblatt would examine position.
-74.16%
Net margin decline while MRVL shows 118.03% growth. Joel Greenblatt would examine position.
-79.07%
EPS decline while MRVL shows 120.18% growth. Joel Greenblatt would examine position.
-79.07%
Diluted EPS decline while MRVL shows 120.18% growth. Joel Greenblatt would examine position.
-1.76%
Both companies reducing share counts. Martin Whitman would check patterns.
-2.28%
Both companies reducing diluted shares. Martin Whitman would check patterns.